| NDC包装代码 | 产品NDC | 产品类型 | 商品名 | 通用名 | 剂型 | 给药途径 | 上市日期 | 结束日期 | 市场类别 | 申请号 | 标签持有者 | 活性成分 | 规格 | 包装描述 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 59651-582-08 | 59651-582 | HUMAN PRESCRIPTION DRUG | Pazopanib | Pazopanib | TABLET, FILM COATED | ORAL | 20241204 | N/A | ANDA | ANDA219034 | Aurobindo Pharma Limited | PAZOPANIB HYDROCHLORIDE | 200 mg/1 | 120 TABLET, FILM COATED in 1 BOTTLE (59651-582-08) |
| 59651-582-30 | 59651-582 | HUMAN PRESCRIPTION DRUG | Pazopanib | Pazopanib | TABLET, FILM COATED | ORAL | 20241204 | N/A | ANDA | ANDA219034 | Aurobindo Pharma Limited | PAZOPANIB HYDROCHLORIDE | 200 mg/1 | 30 TABLET, FILM COATED in 1 BOTTLE (59651-582-30) |
| 59651-582-90 | 59651-582 | HUMAN PRESCRIPTION DRUG | Pazopanib | Pazopanib | TABLET, FILM COATED | ORAL | 20241204 | N/A | ANDA | ANDA219034 | Aurobindo Pharma Limited | PAZOPANIB HYDROCHLORIDE | 200 mg/1 | 90 TABLET, FILM COATED in 1 BOTTLE (59651-582-90) |